Vanda Pharmaceuticals reported $609.1M in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acadia Pharmaceuticals ACAD:US $ 612.77M 11.48M
Acorda Therapeutics ACOR:US $ 406.31M 17.83M
Agios Pharmaceuticals AGIO:US $ 1252.47M 83.39M
Akebia Therapeutics AKBA:US $ 521.8M 13.55M
Alnylam Pharmaceuticals ALNY:US $ 3330.42M 103.13M
Anika Therapeutics ANIK:US $ 354.12M 11.88M
Arrowhead Research ARWR:US $ 751.78M 48.21M
AstraZeneca AZN:LN 7932612.74M 297425.43M
Bluebird Bio BLUE:US $ 573.59M 82.52M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Clovis Oncology CLVS:US $ 392.86M 58.67M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Enanta Pharmaceuticals ENTA:US $ 385.21M 21.6M
Esperion Therapeutics ESPR:US $ 303.98M 38.87M
Halozyme Therapeutics HALO:US $ 1781.39M 619.14M
Heron Therapeutics HRTX:US $ 243.96M 29.76M
Insmed INSM:US $ 1.05B 99.96M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
Lexicon Pharmaceuticals LXRX:US $ 112.32M 23.85M
Ligand Pharmaceuticals LGND:US $ 1076.29M 28.9M
Minerva Neurosciences NERV:US $ 64.96M 5.66M
Moderna Inc MRNA:US 26.04B 1.57B
Novartis NVS:US $ 122910M 2308M
Ptc Therapeutics PTCT:US $ 1804.06M 4.47M
Puma Biotechnology PBYI:US $ 193.65M 7.03M
Sangamo Biosciences SGMO:US $ 617.13M 37.18M
Takeda 4502:JP Y 14065426M 887408M
Teva Pharmaceutical TEVA:IT 45.93B 1.13B
Ultragenyx Pharmaceutical RARE:US $ 1320.63M 63.4M
Vanda Pharmaceuticals VNDA:US $ 609.1M 5.54M
Veracyte VCYT:US $ 1144.2M 29.39M